Abdominal Cancer Surgery

Cytoreductive surgery and heated chemotherapy

Heated Chemotherapy or Hot Chemo – formally known as hyperthermic intraperitoneal chemotherapy (HIPEC) – is a procedure in which following a surgical case to remove existing visual cancer, the patient’s abdominal cavity is“washed” with a heated chemotherapy solution in efforts to kill any cancer that the surgery couldn’t get to. Heated chemo wash procedures are typically used on patients with rare abdominal cancers, ovarian cancer, cancers that have spread from nearby organs to the abdominal lining and those that have unfortunately returned.

Heated chemo is incorporated with additional treatment options and in association with other surgical approaches to enhance the overall effectiveness of treatment.  In advanced ovarian cancer, heated chemo has been demonstrated to increase survival.

Peritoneal Neoplastic Disease program

CHI Health Creighton University Medical Center - Bergan Mercy Peritoneal Neoplastic Disease program in Omaha was established in 2002 by CHI Health oncology surgeon Dr. Brian Loggie. In the early 90s, during his tenure at Wake Forest University Baptist Medical Center, Dr. Loggie’s frustration with the lack of treatment options for peritoneal cancer led him to develop a revolutionary treatment that provides hope for patients with peritoneal cancer, including those in the late stages.

Dr. Loggie's expertise is in surgical oncology and the management and treatment of rare cancers has earned him a national and international reputation for his expertise in the field. Patients from all 50 states and several countries have been treated through the Peritoneal Neoplastic Disease program.

Cancers we treat

The Peritoneal Neoplastic Disease program staff treats individuals who have rare diseases such as:

  • malignant peritoneal mesothelioma
  • cutaneous malignant melanoma
  • peritoneal carcinomatosis and malignant ascites
  • abdominopelvic and retroperitoneal sarcomas
  • pseudomyxoma peritonei
  • management of complex primary, recurrent solid tumors and appendix neoplasms
  • Patients with more common underlying diseases such as colon cancer or ovarian cancer also are treated through the program

For more information

For more information about the Peritoneal Neoplastic Disease program at CUMC - Bergan Mercy, please call (402) 717-0090.

Our Providers

Brian Loggie, MD

Colorectal Surgery,
Surgical Oncology

Holly Sennett, APRN, NP

Surgical Oncology

Sarah P. Thayer, MD, PhD

Surgical Oncology